Erratum to: Diabetologia
DOI 10.1007/s00125-010-1922-6
Unfortunately, the values for urinary ACR in the ‘Month 6 characteristics’ section of Table 1 were incorrect. They should have read 124 (46–249) for those in the group with serum potassium <5.0 mmol/l and 139 (51–291) for those in the group with serum potassium ≥5.0 mmol/l.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00125-010-1922-6.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 2.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by-nc/2.0/.
About this article
Cite this article
Miao, Y., Dobre, D., Lambers Heerspink, H.J. et al. Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia 54, 2209 (2011). https://doi.org/10.1007/s00125-011-2215-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-011-2215-4